Recently, Easy Health, a subsidiary of Easy Group, a health security technology platform, and Qilu Pharmaceutical Group, a leading pharmaceutical company, jointly launched a strategic cooperation in orthopedic health, with the goal of improving the bone health of citizens, from science popularization, early screening, medicine and other aspects. In this context, the "Orthopaedic Life" project of 1,000 hospitals and 10,000 doctors has been launched nationwide, and the project will invite tens of thousands of famous orthopedic doctors from thousands of hospitals to participate in the co-creation, and output health science content including **, so that the public can understand the pathogenesis, preventive measures and best plans of osteoporosis, enhance bone health care capabilities, and improve health literacy.
The "Healthy China 2030" Planning Outline and the "Healthy China Initiative" take improving the health literacy level of the whole population as an important indicator, emphasizing the popularization of healthy life and strengthening health education. And bone health is the cornerstone of every person's overall physical health. There are a large number of people with low bone mass in China. It is the largest country in the world with osteoporosis, and China accounts for nearly half of the more than 200 million osteoporosis patients in the world. And the survey shows that the age of osteoporosis is gradually decreasing, and it is no longer the "patent" of the elderly. Osteoporosis not only causes suffering to patients, but also places a heavy burden on families and society. Therefore, paying attention to bone health is an indispensable step for the general public to improve health literacy and maintain physical health.
The goal of this cooperation is to improve the bone health of the people, and the two parties will give full play to their respective resource advantages and innovative scientific and technological capabilities. In the production of scientific and educational content, while linking the national orthopedic doctors, it will also use the easy group "easy to ask doctors."GPT's self-developed medical model, with the blessing of AIGC, makes content production more efficient, more accurate, and more diverse. In terms of publicity and promotion channels, it will rely on the whole scenario of health security of Easy Group, and reach tens of millions of families through its Doer Internet Hospital and Easy Public Welfare Platform.
Easy Health is a health management organization under Easy Group that provides physical examination, consultation, medical treatment, health care and other services, with a cooperative hospital network covering major cities across the country, relying on Easy Group's strong customer service system and technical empowerment capabilities, it is committed to solving people's health problems more efficiently and improving the quality of life.
Qilu Pharmaceutical Group is a large-scale comprehensive modern pharmaceutical enterprise in China, ranking fifth in the "2022 Top 100 Chinese Pharmaceutical Industry List". Since its establishment, it has always adhered to the innovation-driven strategy to achieve high-quality development, 62 drugs have been listed for the first time or exclusively in China, and 7 drugs have won the second prize of the National Science and Technology Progress Award. "Great medical sincerity, family and country in the world" is the core corporate culture of Qilu Pharmaceutical, which has been actively participating in various social welfare activities for many years, and writing Qilu's great love with practical actions.
Through the "Scleric Bone Life" medical science and education project, Easy Group and Qilu Pharmaceutical are committed to improving the level of national bone health. The cooperation between the two sides will give full play to the strength of medical expertise and scientific and technological innovation, not only to care for the health of individual citizens, but also to actively invest in the overall health of the society, and jointly write a great chapter in medical care and public welfare.